Inactive

Notice Type: 0011721225 Sources Sought Synopsis: The purpose of this sources sought notice is to conduct market research to determine if responsible sources exist, to assist in determining if this eff... Notice Type: 0011721225 Sources Sought Synopsis: The purpose of this sources sought notice is to conduct market research to determine if responsible sources exist, to assist in determining if this effort can be competitive and/or a total Small Business Set-Aside. The proposed North American Industry Classification System (NAICS) Code is 325412 with a corresponding size standard of 1,250 employees. The Government will use this information to determine the best acquisition strategy for this procurement. The Government is interested in all small businesses to include 8(a), Service-Disabled Veteran-Owned, HubZone, and Women-Owned small business concerns. The Regional Health Contracting Office - Central, Fort Sam Houston, Texas, is seeking potential sources to provide only FDA approved Ga-68 Dotatate and Lu-177 Dotatate products for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors and treatment of somatostatin receptor-positive gastroenterpancreatic, when clinical evaluation warrants the treatment and use at Brooke Army Medical Center (BAMC). The Period of Performance (POP) will be a (1) base period from 1 January 2022 – 30 September 2022. Contractors responding to this sources sought notice are advised their response does not ensure participation in future solicitations or contract awards. The Government will not reimburse any company or individual for any expense associated with preparation or participation in this research. Interested parties should e-mail responses to roland.jasso.civ@mail.mil by the date identified below. Contractor responses to Salient Characteristics: Dotatate Salient Characteristics Ga-68 Dotatate Must be FDA approved. Must be Ga-68 Dotatate. Must be a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors. Compounded Ga-68 Dotatate must be delivered to Brooke Army Medical Center, Nuclear Medicine Service in less than 2 hours from completion of compounded radiopharmaceutical. Lu-177 Dotatate Must be FDA approved. Must be Lu-177 Dotatate Must be indicated for treatment of somatostatin receptor-positive gastroenterpancreatic neuroendocrine tumors, including foregut, midgut, and hindgut neuroendocrine tumors. Should be a 4 dose treatment regimen given every 8 weeks. Responses shall also include the following: The size of your business with regard to North American Industry Classification System (NAICS) code 325412 per the standard described in Federal Acquisition Regulation (FAR) Part 19.102 (FAR available at http://farsite.hill.af.mil). If you believe this study should be performed under a different NAICS code, please recommend an alternate NAICS code and the rationale for the alternative code. Recommended Bid schedule (Contract Line item) and invoicing recommendations Company name, DUNS, CAGE, Contact information. Submit no later than 6 December 2021, by 3:00PM CST. Contracting Office Address: Regional Health Contracting Office-Central, 3851 Roger Brooke Drive, Joint Base San Antonio - Fort Sam Houston, TX 78234-6200 Place of Performance: San Antonio Medical Military Center (SAMMC), Fort Sam Houston, Texas 78234-4504 Point of Contact(s): Roland Jasso, 210-221-4903